OncoCyte Corporation (NASDAQ:OCX) Results from Key R&D Validation Study January 29, 2019 8:30 AM ET Company Participants Bob Yedid – Managing Director-LifeSci Advisors Bill Annett – President and Chief Executive Officer Lyndal Hesterberg – Senior Vice President-Research and Development Al Parker – Chief Operating Officer Ronnie Andrews – Board of Director-Science and Technology Committee Conference Call Participants Paul Knight – Janney Montgomery Scott Caroline Palomeque – Maxim Group Kevin DeGeeter – Oppe ...